Basit öğe kaydını göster

dc.contributor.authorBÜYÜKGÖL, Hüseyin
dc.contributor.authorİLİK, Faik
dc.contributor.authorERTEM, Devrimsel Harika
dc.date.accessioned2020-08-07T13:24:38Z
dc.date.available2020-08-07T13:24:38Z
dc.date.issued2019-12
dc.identifier10.1097/NMD.0000000000001101
dc.identifier.urihttp://hdl.handle.net/20.500.12498/3338
dc.description.abstractCharles Bonnet syndrome (CBS) is characterized by visual hallucinations with preservation of cognitive abilities. The hallucinations consist mostly of vivid (realistic) objects and tend to reoccur. Here, we evaluate the etiologies, symptoms, treatments, and prognoses of 13 CBS cases. All patients had visual hallucinations but were normal on cognitive and psychiatric assessments. Patient demographic and clinical characteristics, treatment options, and 3-month follow-up data were retrospectively reviewed. The possible causes of CBS and what the patients perceived during their hallucinations were recorded. Antipsychotic agents, such as risperidone and quetiapine, and anticonvulsants, such as levetiracetam, may be effective in some cases.
dc.language.isoeng
dc.sourceThe Journal of nervous and mental disease
dc.subjectCharles Bonnet Syndrome
dc.subjectVisual Impairment
dc.subjectHallucinations
dc.titleEvaluation of the Clinical Features, Management, and Prognoses of Patients With Charles Bonnet Syndrome.
dc.typeMakale


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster